Drugmakers have greeted 2025, implementing price hikes for 583 products within the first two days of the new year, according ...

Here is the list of combination asthma inhalers currently licensed by the FDA: Asthma inhalers also differ based on how the ...

FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting ...

Patients would pay no more than $25 for certain name-brand medications to treat ... to manage chronic illnesses – like needles, inhalers and monitors – was not included in the final compromise ...

BOSTON — Patients would pay no more than $25 for certain name-brand medications to treat ... like needles, inhalers and monitors, was not included in the final compromise, a Friedman aide ...

Gireesh Babu, New Delhi Saturday, January 18, 2025, 08:00 Hrs [IST] ...

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Throughout 2024, biotech and pharmaceutical companies stepped up their efforts to educate the public about various disease states and medications that can improve ... behind an asthma patient with a ...

Patients would pay no more than $25 for certain name-brand medications to treat ... to manage chronic illnesses, like needles, inhalers and monitors, was not included in the final compromise ...

On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

Navigating the large universe of small-cap stocks can be a daunting task, which is why most investors leave the stock picking ...